· elita will continue to be the driving force for maintaining and developing the european liver...
TRANSCRIPT
1
4th ELITA-ELTR Winter Meeting April 3 - 5, 2008Cortina d’Ampezzo, ItalyAlexander Girardi Congress HallFINAL PROGRAMME
European Liver and IntestineTransplant Associationwww.elita.org
European LiverTransplant Registrywww.eltr.org
WE INNOVATEHEALTHCARE
Researching to improve your quality of life.
For over 110 years Roche has been doing
pioneering work in the research, develop-
ment, production and marketing of novel,
individualised healthcare solutions. We
use the latest findings from our research
activities to improve people’s wellbeing
and health. We also have an equally long-
standing commitment to the arts and
humanitarian causes.
3
Welcome Address 4
Committees 5
Patronages 6
Programme Overview 7
Scientific Programme 8
Young Investigator Award 26
5th ELITA – ELTR Winter Meeting 27
Scientific Information 28
General Information 30
Acknowledgements 32
Exhibit 33
Con
tent
s
Dear Colleagues and Friends,
It is our pleasure to welcome you to the 4th ELlTA-ELTR Winter Meeting. Since its foundation in 1993 by the European pioneers in liver transplantation, ELTA has brought together specialists with a common interest in liver transplantation and since 2005 in intestinal transplantation. Therefore the name of the society was changed to ELITA - European Liver and Intestine Transplant Association (www.elita.org), which represents the liver and intestine transplant community within ESOT (www.esot.org).ELITA will continue to be the driving force for maintaining and developing the European Liver Transplant Registry - ELTR (www.eltr.org) - with audited data on over 77.000 liver transplants and living donor data base. This has all been made possible because of the efforts by all contributing transplant centers and the financial support of industrial sponsors. The 4th ELlTA-ELTR Winter Meeting aims at bringing together all specialists in liver transplantation and intestinal transplantation including transplant coordinators and data managers. Lectures will be held by experts on the most challenging themes such as hepatocellular carcinoma, hepatitis C and intestinal transplantation. The results of ELTR studies will be discussed and further research opportunities will be investigated during the meeting. We are repeating the very positive and stimulating experience of the previous editions of the Winter Meeting, which is the “My worst case” session.Moreover, we are very pleased to communicate that the accepted abstracts are published in Transplant International, thanks to the important collaboration with the editor Prof. Ferdinand Mühlbacher.Moreover, the past members of the ELITA Board will be invited to participate in the ELITA REUNION which will take place at the Winter Meeting.Cortina d’Ampezzo is located in the heart of the Dolomites, surrounded by dramatic sceneries. The Ampezzo Valley has long been considered one of the most well-known tourist destination in the world and offers a unique opportunity to combine work and rest through sport, nature and culture. Cortina is dramatic peaks, amazing hikes, enchanting landscape.Cortina offers the best available structures for all congress events requirements. The wide and flexible range of services offered guarantees the highest standards in congress facilities in a truly exclusive location, with the new Alexander Girardi Congress Hall to host conferences.To enforce the enchanting atmosphere that Cortina does create, invited speeches by transplant pioneers will further sharpen our knowledge.
We wish you a fruitful conference!
Patrizia BurraELITA Chairman and Local OrganizerOn behalf of ELITA Board Members
4
ELITA Board Chairman Patrizia Burra, Padova, Italy Vice Chairman Michael Olausson, Gotheborg, Sweden Secretary Robert Porte, Groningen, The Netherlands Treasurer Michele Colledan, Bergamo, Italy Custodian of ELTR Renè Adam, Paris, France Member Gabriela A. Berlakovich, Vienna, Austria Member Andrew K. Burroughs, London, United Kingdom Member Bernard De Hemptinne, Ghent, Belgium Member Pietro Majno, Geneva, Switzerland Member Paolo Muiesan, London, United Kingdom Member Jacques Pirenne, Leuven, Belgium
ELITA – ELTR Patrizia BurraWINTER MEETING Chair Gastroenterology, Multivisceral Transplant Unit Department of Surgical and Gastroenterological Sciences University of Padova, Padova, Italy Ph: +39 049 8212892 - Fax +39 049 8218727 [email protected]
ELITA – ELTR WINTER MEETING Renè Adam, Paris, FranceScientific Secretariat Patrizia Burra, Padova, Italy Andrew K.Burroughs, London, United Kingdom Michele Colledan, Bergamo, Italy Alfred Königsrainer, Tubingen, Germany Pietro Majno, Geneva, Switzerland Darius Mirza, Birmingham, United Kingdom Michael Olausson, Gotheborg, Sweden
ELITA Secretary Robert J. Porte Department of Surgery Section Hepatobiliary Surgery and Liver Transplantation University Medical Center Groningen, Groningen The Netherlands - [email protected]
ELITA – ELTR WINTER MEETING Annalisa PonchiaOrganizing Secretariat c/o ESOT Office - Corso del Popolo, 8 - 35131 Padova, Italy Ph: +39 049 3005796 - Fax +39 049 2106306 [email protected]
Local Co-Organizers Patrizio Bo Fiorenzo Moret Francesca Vasoin De Prosperi Laura Boaretto Tormen
Committees5
6 6
Senato della Repubblica
Regione del Veneto
Comune di Cortina d’Ampezzo
Università degli Studi di Padova
Facoltà di Medicina e Chirurgia di Padova
Azienda Ospedaliera di Padova
ULSS 16 di Padova
ULSS 1 di Belluno
Istituto Codivilla Putti di Cortina
S.I.G.E. Società Italiana di Gastroenterologia
A.I.S.F. Associazione Italiana per lo Studio del Fegato
Under the Patronage
Thursday April, 3 Friday April, 4 Saturday April, 5
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
SESSION 2Update on liver transplantation
for hepatocellur carcinoma
SESSION 4Challenges in
livertransplantation
for HCV
ORAL 3ELTR
Studies
COFFEE BREAK
COFFEE BREAKSESSION 2(continue) ORAL 4
My worst case
SESSION 5ELTR Studies
ORAL 6Small Bowel
and Pediatric Transplantation
ORAL 5Hepatitis C andQuality of life
CLOSING
OPENING & SESSION 1
SESSION 3How to improve the results of small bowel
transplantation in Europe?
ORAL 1Basic Science
ORAL 2Hepatocellular
Carcinoma
POSTER OPENING ANDWELCOME COCKTAIL
SATELLITE SYMPOSIUM GRIFOLS
SOCIAL DINNER
Senato della Repubblica
Regione del Veneto
Comune di Cortina d’Ampezzo
Università degli Studi di Padova
Facoltà di Medicina e Chirurgia di Padova
Azienda Ospedaliera di Padova
ULSS 16 di Padova
ULSS 1 di Belluno
Istituto Codivilla Putti di Cortina
S.I.G.E. Società Italiana di Gastroenterologia
A.I.S.F. Associazione Italiana per lo Studio del Fegato
Programme overview7
Scientific Programme8
Thursday, 3 April, 2008
OPENING & SESSION 1 ROOM F 17:00 - 18:40
17:00 Welcome Address and Introduction
Patrizia Burra, Padova, Italy ELITA Chairman and Local Organizer
Remo Naccarato, Padova, Italy
Ferdinand Mühlbacher, Vienna, Austria ESOT President
INVITED LECTURES
Chairs: Patrizia Burra, Padova, Italy Lajos Okolicsanyi, Treviso, Italy
17:10 Neurocognitive changes at high altitude Giuseppe Sartori, Padova, Italy
17:40 To be an editor of a scientific society journal today Massimo Colombo, Milan, Italy
18:10 Surgery, transplantation and art Sir Roy Calne, London, United Kingdom
18:40 Poster Opening and Welcome Cocktail
Exhibition of Paintings and Sculptures Artists: Lucio Caccamo, Sir Roy Calne, Fransiska Könisgrainer, Bea Lerut, Franco
Cimitan and Massimo Nube presented by Santo Stefano Art Gallery in Venice
Scientific Programme9
Friday, 4 April, 2008
SESSION 2UPDATE ON LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMAROOM F 08:30 - 12:00
Chairs: Massimo Colombo, Milan, Italy Erica Villa, Modena, Italy
08:30 Need for a scoring system for HCC on cirrhotic liver: what do we have, what do we need?
Umberto Cillo, Padova, Italy
08:50 Role for imaging techniques in staging HCC before transplantation Luigi Bolondi, Bologna, Italy
09:10 Management on the waiting list: treatments or prioritisation ? Ivo Graziadei, Innsbruck, Austria
09:30 Results on extended criteria from the Metroticket Study Enrico Regalia, Milan, Italy
09:50 Downstaging procedures and their efficacy Massimo Malagò, London, United Kingdom
10:10 Coffee break
10:30 Living related liver transplantation for HCC. Expanding the limits ? Restricting the limits?
Pietro Majno, Geneva, Switzerland
10:50 Liver transplantation for HCC in non cirrhotic livers Robert Porte, Groningen, The Netherlands
11:10 Early/very early HCC and liver transplantation: report from ITALICA (Italian Liver Cancer)
Fabio Farinati, Padova, Italy
11:30 Immunosuppression after liver transplantation for HCC: results from The Silver Study Edward Geissler, Regensburg, Germany
11:50 Summary and key points Pietro Majno, Geneva, Switzerland
Scientific Programme
SESSION 3 HOW TO IMPROVE THE RESULTS OF SMALL BOWEL TRANSPLANTATION IN
EUROPE? ROOM F 16:00 - 18:00
Chairs: Giacomo Carlo Sturniolo, Padova, Italy Michele Colledan, Bergamo, Italy
16:00 Update from the International registry Michael Olausson, Gotheborg, Sweden
16:20 Do we need a European Registry on intestinal transplantation? Results from the European single centers
Gustaf Herlenius, Gotheborg, Sweden
16:40 Bridging procedures before small bowel transplantation Antonio Pinna, Bologna, Italy
17:00 Infections, late rejection, PTLD, GVHD following small bowel transplantation Darius Mirza, Birmingham, United Kingdom
17:20 Nutrition and rehabilitation before and after small bowel transplantation Manila Candusso, Bergamo, Italy
17:40 Stem cell therapy as alternative option to small bowel transplantation Malcolm Alison, London, United Kingdom
10
Scientific Programme
ORAL COMMUNICATIONS 1 – BASIC SCIENCE ROOM BOITE 16:00 - 17:00
Chairs: Paolo Muiesan, London, United Kingdom Robert Porte, Groningen, The Netherlands
16:00 O01 MELATONIN PROTECTS FROM HEPATIC REPERFUSION INJURY THROUGH INHIBITION OF IKK AND JNK PATHWAYS AND MODIFICATION OF CELL PROLIFERATION
Arash Nickkholgh, Rui Liang, Katrin Hoffmann, Michael Kern, Heinz Schneider, Michael Sobirey, Markus Zorn, Markus W. Böchler, Peter Schemmer, Dept. of General Surgery, Ruprecht-Karls University, Heidelberg, Germany; Dept. of Pathology, Ruprecht-Karls University, Heidelberg, Germany; HealthEcon AG, Basel, Switzerland; Nutri~Fit GmbH & Co KG, Mühlen, Germany; Central Laboratory, Ruprecht-Karls University, Heidelberg, Germany
16:12 O02 HUMAN UMBILICAL CORD BLOOD MESENCHYMAL STEM CELLS CAN CONTRIBUTE TO LIVER REGENERATION IN AN ANIMAL MODEL OF CHEMICAL-INDUCED LIVER INJURY
Chiara Calore, Michela Turetta, Annalisa Masier, Rosa Di Liddo, Tatiana Chioato, Donatella Pellican, Patrizio Bo, Debora Bizzarro, Silvia Tomat, Francesco P. Russo, Mariateresa Conconi, Pierpaolo Parnigotto, Patrizia Burra, Dept. of Pharmaceutical Sciences, University of Padova, Italy; Dept. of Surgical and Gastroenterological Sciences, University of Padova, Italy; Obstetrics and Gynecology Unit, General Hospital, Cittadella, Padova, Italy
16:24 O03 THE ROLE OF BILE SALT TOXICITY IN THE PATHOGENESIS OF BILE DUCT INJURY AFTER NON–HEART-BEATING PORCINE LIVER TRANSPLANTATION
Marit J. Yska, Diethard Monbaliu, Theo A. Schuurs, Annette SH Gouw, Olivier NH Kahmann, Dorien S. Visser, Jacques Pirenne, Robert J. Porte, Department of Abdominal Transplant Surgery and Coordination, University Hospitals, Leuven, Belgium; Surgical Research Laboratory, University Medical Center, Groningen, The Netherlands; Department of Pathology, University Medical Center, Groningen, The Netherlands; Department of Surgery and Liver Transplantation, University Medical Center, Groningen, The Netherlands
11
Scientific Programme
16:36 O04 PROSPECTIVE STUDY OF NATURAL KILLER (NK) CELL PHENOTYPE IN RECURRING HCV INFECTION FOLLOWING LIVER TRANSPLANTATION
B. Oliviero, S. Varchetta, F. Donato, F. Agnelli, G. Rossi, M. Berra, C. Rigamonti, M. Colombo, D. Mavilio, M. U. Mondelli, Infectious Diseases, IRCCS Fondazione San Matteo and University of Pavia, Pavia, Italy; Gastroenterology and Liver Transplantation Unit, IRCCS Fondazione Policlinico-Mangiagalli-Regina Elena, Milan, Italy; Laboratory of Immunoregulation, NIAID, NIH, Bethesda, USA
16:48 O05 HISTOLOGICAL STUDIES IN VARIOUS MODELS OF ACUTE HEPATIC FAILURE Martin Schenk, Christian Thiel, Karolin Knubben, Alexander Etspueler, Frieder Dechent, Anja
Zeller, Karoline Lehrach, Matthias H. Morgalla, Alfred Königsrainer, Universitätsklinikum Tübingen, Klinik für Allgemeine, Viszeral- und Transplantationschirurgie, Klinik für Neurochirurgie, Tübingen, Germany
ORAL COMMUNICATIONS 2 – HEPATOCELLULAR CARCINOMA ROOM BOITE 17:00 - 18:00
Chairs: Bernard de Hemptinne, Ghent, Belgium Pietro Majno, Geneva, Switzerland 17:00 O06 PREOPERATIVE FINE NEEDLE ASPIRATION-BIOPSY IN PATIENTS WITH LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA. WHY USE IT? Baltasar Perez-Saborido, Santos Jimenez-Galanes Marchán, Juan Carlos Meneu D¡az,
Yiliam Fundora Suarez, Almudena Moreno Elola-Olaso, Maria Donat Garrido, Vanessa Barra Valencia, Alberto Gimeno Calvo, Carlos Jimenez Romero, Enrique Moreno Gonzalez, Surgery and Abdominal Organs Transplantation, 12 de Octubre University Hospital, Madrid, Spain
17:12 O07 VALIDATION OF THE BCLC PROGNOSTIC SYSTEM IN SURGICAL HCC PATIENS. IS NECESSARY TO MODIFY THE BCLC TREATMENT ALGORITHM?
Alessandro Vitale, Francesco D’Amico, Enrico Gringeri, Michele Valmasoni, Amedeo Carraio, Paola Violi, Alberto Pauletto, Pasqule Bonsignore, Patrizia Burra, Fabio Farinati, Francesco Jr D’Amico, Davide F. D’Amico, Umberto Cillo, Istituto Oncologico Veneto – IRCCS, Unità di Chirurgia Oncologica, Padova, Italy; Dipartimento di Scienze Chirurgiche e Gastroenterologiche-Università di Padova, Unità di Chirurgia Epatobiliare e Trapianto Epatico, Padova, Italy
17:24 O08 THE IMPACT OF HCC ON 3-YEAR SURVIVAL FOLLOWING LIVER TRANSPLANTATION IN THE MELD ERA
Martina Gambato, Marco Senzolo, Annalisa Masier, Giacomo Germani, Daniele Canova,
12
Scientific Programme
Eleonora De Martin, Silvia Tomat, Francesco P. Russo, Alessandro Vitale, Umberto Cillo, Burra Patrizia, Department of Surgical and Gastroenterological Sciences, Gastroenterology Unit, Padova, Italy
17:36 O09 CALCINEURIN INHIBITORS AND HCC RECURRENCE AFTER LT Marco Vivarelli, Alessandro Cucchetti, Giuliano La Barba, Massimo Del Gaudio, Matteo
Ravaioli, Matteo Cescon, Augusto Lauro, Gian Luca Grazi, Antonio D. Pinna, Surgery and Transplantation, University of Bologna, Policlinico S.Orsola, Bologna, Italy
17:48 O10 RECURRENT cccDNA POSITIVE HEPATOCELLULAR CARCINOMA 10 YEARS AFTER LIVER TRANSPLANTATION
Ilaria Lenci, Giuseppe Tisone, Laura Tariciotti, Daniele Di Paolo, Marco Ciotti, Fabio Marcuccilli, Carlo F. Perno, Mario Angelico, Hepatology and Liver Transplantation Center, Tor Vergata University, Rome, Italy; Laboratory of Molecular Virology, Tor Vergata University, Rome, Italy
GRIFOLS CORPORATE SATELLITE SYMPOSIUM ROOM F 18:00 - 19:00
OPTIMIZING PROPHYLAXIS WITH IMMUNOGLOBULINS AFTER LIVER TRANSPLANTATION
Chairs: Patrizia Burra, Padova, Italy Ivo Graziadei, Innsbruck, Austria
18:00 Immunoglobulins and the prevention of HBV recurrence: an update Patrizia Burra, Padova, Italy
18:15 Fixed schedule prophylaxis with intramuscular immunoglobulins: background, efficacy and implications for practice.
Alessandro Franchello, Turin, Italy
18:30 Intramuscular versus intravenous route: How, when and why? Stefano Fagiuoli, Bergamo, Italy
18:45 Panel discussion and conclusions
WINTER MEETING & ELITA REUNION DINNER
LECTURE 20:30 The past history and new prospectives for ELITA Paul Mc Master, Birmingham, United Kingdom
13
Scientific Programme14
Saturday, 5 April, 2008
SESSION 4 CHALLENGES IN LIVER TRANSPLANTATION FOR HCV ROOM F 08:30 - 11:00
Chairs: Stefano Fagiuoli, Bergamo, Italy Alfred Königsrainer, Tübingen, Germany
08:30 How far can we go with donor/recipient match in HCV positive recipients Patrizia Burra, Padova, Italy
08:55 How to follow up the progression of fibrosis due to HCV recurrence after liver transplantation ?
Luca Belli, Milan, Italy
09:20 New strategies for antiviral therapy in HCV recurrence after liver transplantation Andrew K. Burroughs, London, United Kingdom
09:45 De novo autoimmune hepatitis in patients transplanted for HCV related liver disease Maria Guido, Padova, Italy
10:10 Discussion
SESSION SUPPORTED WITH AN UNRESTRICTED GRANT BY
10:30 Coffee break
Scientific Programme15
ORAL COMMUNICATIONS 3 – ELTR STUDIES ROOM BOITE 08:30 - 09:30
Chairs: René Adam, Paris, France, Lucio Caccamo, Milan, Italy
08:30 O11 “RESCUE ALLOCATION” IN LIVER TRANSPLANTATION WITHIN EUROTRANSPLANT: A SINGLE CENTRE EXPERIENCE
Peter Schemmer, Arash Nickkholgh, Till Gerling, Jürgen Weitz, Markus W. Böchler, Jan Schmidt, Dept. of General Surgery, Ruprecht-Karls University, Heidelberg, Germany; ET (Eurotransplant), Leiden, The Netherlands
08:40 O12 PLATELET TRANSFUSIONS DURING LIVER TRANSPLANTATION ARE ASSOCIATED WITH INCREASED POST-OPERATIVE MORTALITY DUE TO ACUTE LUNG INJURY
Ilona T.A. Pereboom, Marieke T. de Boer, Els B. Haagsma, Herman G.D. Hendriks, Robert J. Porte, Surgery University Medical Center, Groningen, The Netherlands; Hepatobiliary Surgery and Liver Transplantation, University Medical Center, Groningen, The Netherlands; Gastroenterology and Hepatology, University Medical Center, Groningen, The Netherlands; Anesthesiology, University Medical Center, Groningen, The Netherlands
08:50 O13 RISK FACTORS IN FAP TRANSPLANTATION Vitor M. Ribeiro, Teresa Coelho, Surgery and Liver Transplantation, Amyloidosis Clinical
Unit, Hospital Santo António, Porto, Portugal
09:00 O14 QUALITY CONTROL OF THE EUROPEAN LIVER TRANSPLANT REGISTRY (ELTR). REPORT OF THE LIVING DONOR LIVER TRANSPLANTATION (LDLT) AUDIT
Vincent H. Karam, Bridget Gunson, Wolfgang Wannoff, Francine Roggen, Juan Carlos Meneu Diaz, René Adam, Centre Hepatobiliaire Hôpital Paul Brousse, Villejuif, France; Liver Labs, The Queen Elizabeth Hospital, Birmingham, United Kingdom; Dept. of audits, Panacea 4 U Limited, Hamburg, Germany; Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium; Servicio de Trasplante de Organos Abdominales, Hospital 12 de Octubre, Madrid, Spain
09:10 O15 LIVER TRANSPLANTATION FOR ALCOHOLIC LIVER DISEASE IN ADULTS IN EUROPE
Marco Senzolo, Patrizia Burra, René Adam, Vincent Karam, Giacomo Germani, James Neuberger, Gastroenterology, Department of Surgical and Gastroenterological Sciences, University-Hospital of Padua, Padua, Italy; ELTR, Centre Hepatobiliaire Hôpital Paul Brousse, Villejuif, France; Liver Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom
Scientific Programme
09:20 O16 15-YEAR EVOLUTION OF LIVER TRANSPLANTATION IN EUROPE René Adam, Vincen H. Karam, John Buckels, John O’Grady, Denis Castaing, Jurgen
Klempnauer, Neville Jamieson, Peter Neuhaus, Jan Lerut, Stephen Pollard, Mauro Salizzoni, Lutz Fischer, Juan Garcia-Valdecasas, Ferdinand Mühlbacher, José Mir, Christopher Broelsch, Patrizia Burra, Centre Hepatobiliaire Hôpital Paul Brousse, Villejuif, France; Queen Elisabeth Medical Center, The Queen Elizabeth Hospital, Birmingham, United Kingdom; Transplantation Surgery, Royal Free Hospital, London, United Kingdom; Klinik für Viszeral-und Transplantationschirurgie, Medizinische Hochschule, Hannover, Germany; Department of Surgery, Addenbrooke’s Hospital, Cambridge, United Kingdom; Klinik für Allgemein-Viszeral- und Transplantationschirurgie,Charité- Campus - Virchow klinikum, Berlin, Germany; Department of Abdominal Surgery, Cliniques Universitaires Saint Luc, Brussels, Belgium; Department of Abdominal Surgery, St Jame’s & Seacroft University Hospital, Leeds, United Kingdom; Centro Trapianti di Fegato, Azienda Ospedaliera S. Giovanni Battista, Torino, Italy; Dept. of Hepatobiliary Surgery, Universitatskrankenhaus Eppendorf, Hamburg, Germany; Gastrointestinal Surgery Department, Hospital Clinic I Provincial de Barcelona, Barcelona, Spain; Transplantationszentrum Klinishe Abteilung für Transplantation, Wien, Austria; Servicio de Medicina Digestiva, Hospital Universitario La Fe, Valencia, Spain; Klinik für Allgemeine und Transplantationschirurgie, C. U. K. GHs Essen, Essen, Germany; Department of Surgery & Gastroenterological Sciences, Università degli Studi di Padova, Padova, Italy and ELITA, the European Liver and Intestine Transplantation Association
16
Scientific Programme
ORAL COMMUNICATIONS 4 – MY WORST CASE ROOM F 11:00 - 12:00
Chairs: Martin Slooff, Groningen,The Netherlands Xavier Rogiers, Ghent, Belgium
11:00 O17 LIVER RETRANSPLANTATION IN A PEDIATRIC PATIENT: THREE GRAFTS IN A THREE YEARS OLD CHILD. WHAT HAPPENED?
Santos Jimenez-Galanes Marchán, Almudena Moreno Elola-Olasao, Juan Carlos Menu Diaz, Baltasar Perez Saborido, Yiliam Fundora Suarez, Vanessa Barra Valencia, Sergio Olivares Pizarro, Alberto Gimeno Calvo, Manuel Abradelo de Usera, Carlos Jimenez Romero, Enrique Moreno Gonzalez, Surgery and Abdominal Organs Transplantation,12 de Octubre University Hospital, Madrid, Spain
11:12 O18 SURGICAL COMPLICATIONS AFTER LIVER TRANSPLANTATION AND WHIPPLE Oystein Bentdal, Tim Scholz, Ivar Gladhaug, Pal-Dag Line, Aksel Foss, Surgical Clinic, Section for Transplant Surgery, Rikshospitalet University Hospital, Oslo, Norway
11:24 O19 SUCCESSFULL LIVER TRANSPLANTATION IN A PATIENT WITH HBV-RELATED CIRRHOSIS AND PRIMARY YOLK SAC TUMOR OF THE LIVER
Ilaria Lenci, Giuseppe Tisone, Leonardo Baiocchi, Simona Francioso, Arianna Brega, Laura Tariciotti, Marco Carbone, Paolo Craboledda, Francesco Callea, Mario Angelico, Hepatology and Liver Transplantation Center, Tor Vergata University, Rome, Italy; Department of Pathology, S. Eugenio Hospital, Rome, Italy
11:36 O20 REFRACTORY GRAFT VERSUS HOST DISEASE FOLLOWING INTESTINAL TRANSPLANTATION
James Davison, Phil J. Darbyshire, Susan V. Beath, Deirdre A. Kelly, Girish L. Gupte, Liver Unit, Birmingham Children’s Hospital, Birmingham, United Kingdom
11:48 O21 EARLY PTLD OF THE LIVER AND BILE DUCT AFTER LIVER TRANSPLANTATION FOR HCV RELATED CIRRHOSIS
Vittorio Corno, Alessandro Lucianetti, Aurelio Sonzogni, Alessandro Rambaldi, Michela Guazzetti, Domenico Pinelli, Marco Zambelli, Maria Clara Dezza, Giovanna Gaffuri, Alessandra Tebaidi, Mario Strazzabosco, Stefano Fagiuoli, General Surgery III, Liver and Lung Transplantation Center, Ospedali Riuniti, Bergamo, Italy; Pathology, Ospedali Riuniti, Bergamo, Italy; Hematology, Ospedali Riuniti, Bergamo, Italy; Infectious Diseases, Ospedali Riuniti, Bergamo, Italy; CeLiver, Ospedali Riuniti, Bergamo, Italy; Gastroenterology, Ospedali Riuniti, Bergamo, Italy
17
Scientific Programme
ORAL COMMUNICATIONS 5 – HEPATITIS C AND QUALITY OF LIFE ROOM BOITE 11:00 - 12:00
Chairs: Andrew K. Burroughs, London, United Kingdom Jan Lerut, Leuven, Belgium
11:00 O22 HEPATITIS C RECURRENCE: SPLIT LIVER VERSUS WHOLE SIZE GRAFT Enzo Andorno, Ferruccio Ravazzoni, Antonio Picciotto, Nicola Morelli, Giuliano Bottino, Marco Casaccia, Davide Piredda, Gloria Immordino, Stefano Di Domenico, Maximiliano Gelli, Ilaria Nardi, Gregorio Santori, Umberto Valente, General and Transplant Surgery, St. Martino Hospital University of Genoa, Genoa, Italy
11:10 O23 FIBROSIS PROGRESSION ON PROTOCOL LIVER BIOPSIES IN PATIENTS WITH OR WITHOUT ANTIVIRAL TREATMENT FOR HCV RECURRENCE FOLLOWING LIVER TRANSPLANTATION (LT)
Eleonora De Martin, Sara Boninsegna, Marco Senzolo, Maria Guido, Francesco P. Russo, Giacomo Germani, Martina Gambato, Annalisa Masier, Giacomo Zanus, Patrizia Burra, Department of Surgical and Gastroenterological Sciences, Gastroenterology, Padua, Italy; Department of Oncological and Surgical Sciences, Pathology Section, Padua, Italy
11:20 O24 STEROIDS AND HCV RECURRENCE AFTER LT: RESULTS OF A PROSPECTIVE TRIAL HEPATITIS C
Marco Vivarelli, Patrizia Burra, Giuliano La Barba, Daniele Canova, Marco Senzolo, Alessandro Cucchetti, Atonia D’Errico, Maria Guido, Roberto Merenda, Daniele Neri, Matteo Zanello, Federico M. Giannini, Gian Luca Grazi, Umberto Cillo, Antonio D. Pinna, Surgery and Transplantation, University of Bologna, Policlinico S.Orsola, Bologna, Italy; Surgical and Gastroenterological Sciences, University of Padua, Padua, Italy; Pathology, Istituto F. Addarii, University of Bologna, Bologna, Italy; Immunosuppressive Drugs, Astellas Pharma Italia, Milan, Italy
11:30 O25 CADAVER AND LIVING DONOR SPLIT LIVER TRANSPLANTATION FROM CADAVER AND LIVING DONOR IN HCV+ RECIPIENTS: A MULTICENTER EXPERIENCE OF AN ITALIAN TRANSPLANT AGENCY
Tullia M. De Feo, Nicola De Fazio, Alberto Brolese, Abdallah Slim, Giorgio Rossi, Michele Colledan, Enzo Adorno, Umberto Baccarani, Enrico Regalia, Matteo Donataccio, Andrea Risaliti, Mauro Cima, Patrizia Burra, Mario Scalamogna, Dept. of Regenerative Medicine, Transplantation Immunology, Fond. IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan, Italy; Dept. of Regenerative Medicine, Transplantation Immunology, Fond. IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena,
18
Scientific Programme
Milan, Italy; Hepato-Biliary Surgery and Liver Transplantation, Az Osp. of Padua, Padua, Italy; Liver Transplantation and Surgery, Az. Osp. Niguarda Cà Granda, Milan, Italy; Liver Transplantation Center, Fond. IRCCS Osp. Maggiore Policlinico, Mangiagalli e Regina Elena, Milan, Italy; Liver and Lung Transplantation Center, Az. Osp. Ospedali Riuniti, Bergamo, Italy; Transplant Center, Az. Osp. Univ. San Martino, Genova, Italy; Dept. of Transplantation, University Hospital, Udine, Italy; Dept. of Surgery and Liver Transplantation, Fond. IRCCS Istituto Nazionale Tumori, Milan, Italy; II Surgery Division, Az. Osp. Borgo Trento, Verona, Italy; Dept. of Digestive Diseases and General Surgery, Az. Osp. Univ. Ospedali Riuniti, Ancona, Italy; U.O. Anestesia, Terapia Intensiva e Serv. Sale Operatorie, Osp. Santa Chiara A.P.S.S., Trento, Italy; Dept. of Surgery and Gastroenterological Sciences, University of Padua, Padua, Italy
11:40 O26 SEXUAL DYSFUNCTION IN MALE BEFORE AND AFTER LIVER TRANSPLANTATION (LT)
Annalisa Masier, Andrea Salonia, Giacomo Germani, Martina Gambato, Eleonora De Martin, Marco Senzolo, Francesco P. Russo, Alberto Brolese, Giacomo C. Sturniolo, Patrizia Burra, Gastroenterology, Department of Surgical and Gastroenterological Sciences, University of Padova, Padova, Italy; Department of Urology, University Vita-Salute San Raffaele, Milano, Italy; Surgery, Department of Surgical and Gastroenterological Sciences, University of Padova, Padova, Italy
11:50 O27 EVALUATION OF PREDICTIVE FACTORS FOR ADHERENCE TO MEDICAL REGIMEN IN PATIENTS BEFORE AND AFTER LIVER TRANSPLANTATION
Giacomo Germani, Daniele Canova, Marco Senzolo, Egle Perissinotto, Annalisa Masier, Francesco Paolo Russo, Martina Gambato, Eleonora De Martin, Giacomo Zanus, Giacomo Carlo Sturniolo, Patrizia Burra, Department of Surgical and Gastroenterological Sciences, Gastroenterology - University of Padua, Padua, Italy; Department of Enviromental Medicine and Public Health, University of Padua, Padua, Italy
19
Scientific Programme
SESSION 5 ELTR STUDIES ROOM F 12:00 - 13:00
Chairs: René Adam, Paris, France Bernard De Hemptinne, Ghent, Belgium
12:00 Alcoholic Liver Disease James Neuberger, Birmingham, United Kingdom
12:15 Non tumor related prognostic factors of liver transplantation for HCC René Adam, Paris, France
12:30 Outcomes of European Split Liver Transplantation Darius Mirza, Birmingham, United Kingdom
12:45 ELTR: what has changed and what is lacking in the new registry Vincent Karam, Paris, France
ORAL COMMUNICATIONS 6 – SMALL BOWEL AND PEDIATRIC TRANSPLANTATION ROOM BOITE 12:00 - 13:00
Chairs: Michael Olausson, Gotheborg, Sweden Jacques Pirenne, Leuven, Belgium
12:00 O28 RISK FACTORS FOR MORTALITY ON THE WAITING LIST FOR COMBINED LIVER AND SMALL BOWEL TRANSPLANTATION
Girish L. Gupte, Carla Lloyd, Deirdre A. Kelly, Susan V. Beath, Liver Unit (including small bowel transplantation), Birmingham Children’s Hospital, Birmingham, United Kingdom
12:12 O29 A NEW NATIONAL PAEDIATRIC DONOR ORGAN ALLOCATION POLICY FOR CHILDREN WAITING FOR INTESTINAL TRANSPLANTATION
Mara Giovanelli, Girish L. Gupte, Phil Pocock, Carla Lloyd, Patrick J. McKiernan, Susan Richards, David A. Mayer, Khalid Sharif, Darius F. Mirza, Liver Unit, Birmingham Children’s Hospital, Birmingham, United Kingdom; Chirurgia III Centro Trapianti di Fegato e Polmone, Ospedali Riuniti, Bergamo, Italy; Department of Statistics, UK Transplant, Bristol, United Kingdom
20
Scientific Programme
12:24 O30 CHRONIC REJECTION AFTER PAEDIATRIC INTESTINAL TRANSPLANTATION: A UK SINGLE CENTRE EXPERIENCE
Mara Giovanelli, Susan V. Beath, Deirdre A. Kelly, Rachel Brown, Katherine Foster, Alistair J. Millar, Khalid Sharif, David A. Mayer, Darius F. Mirza, Girish L. Gupte, Liver Unit, Birmingham Children’s Hospital and Chirurgia 3 Liver & Lung Transplant Centre Ospedali Riuniti, Bergamo, Italy; Liver Unit, Birmingham Children’s Hospital, Birmingham, United Kingdom
12:36 O31 PRE-EMPTIVE MANAGEMENT OF ANASTOMOTIC BILIARY STENOSES AFTER PEDIATRIC LIVER TRANSPLANTATION
Vittorio Corno, Laura Locatelli, Domenico Pinelli, Alessandro Lucianetti, Aurelio Sonzogni, Roberto Agazzi, Maria Clara Dezza, Marco Zambelli, Michela Guazzetti, Daniela Codazzi, Manila Candusso, Paola Stroppa, Michela Bravi, Giuliano Torre, Michele Colledan, General Surgery, Liver and Lung Transplantion Center, Ospedali Riuniti, Bergamo, Italy; Pediatrics, Ospedali Riuniti, Bergamo, Italy; Pathology, Ospedali Riuniti, Bergamo, Italy; Radiology, Ospedali Riuniti, Bergamo, Italy; Pediatric Intensive Care Unit, Ospedali Riuniti, Bergamo, Italy
12:48 O32 RETRANSPLANTATION RATE IS SIGNIFICANTLY HIGHER IN DONATION AFTER CARDIAC DEATH AND INDIPENDENT FROM THE RECIPIENT STATUS
Maria Clara Dezza, F. Berrevoet, Maurizio Sainz Barriga, A. Rossetto, Xavier Rogiers, Bernard De Hemptinne, Roberto Troisi, Hepatobiliary Service, Ghent University Hospital, Ghent, Belgium
ROOM F 13:00 Closure of the Meeting
21
Posters
Posters HEPATOCELLULAR CARCINOMA
P01 TUMOR RECURRENCE AFTER LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA: RECURRENCE PATHWAY AND PROGNOSTIC FACTORS Baltasar Perez-Saborido, Santos Jimenez-Galanes Marchán, Juan Carlos Meneu-Djaz,
Carlos Jimenez-Romero, Almudena Elola-Olaso, Yiliam Fundora Suarez, Vanessa Barra Valencia, Manuel Abradelo de Usera, Alberto Gimeno Calvo, Enrique Moreno-Gonzalez, Surgery and Abdominal Organs Transplantation, 12 de Octubre University Hospital, Madrid, Spain
P02 RESULTS OF RESECTION AND TRANSPLANTATION FOR HCC IN CIRRHOSIS AND NON-CIRRHOSIS HEPATOCELLULAR CARCINOMA
Fadi Rayya, Department for Visceral and Transplant, University Hospital, Leipzig, Germany
P03 MOLECULAR STAGING OF HCC PATIENTS BEFORE ELEGIBLE FOR RADICAL THERAPIES
Alessandro Vitale, Guglielmo Ometto, Alberto Brolese, Giacomo Zanus, Daniele Neri, Patrizia Boccagni, Francesco D’Amico, Francesco A. Ciarleglio, Patrizia Burra, Davide F. D’Amico, Umberto Cillo, Istituto Oncologico Veneto – IRCCS, Chirurgia Oncologica; Dipartimento di Scienze Chirurgiche e Gastroenterologiche, Università di Padova, Unit of Chiurgia Epatobiliare e Trapianto Epatico, Padova, Italy
P04 INTERPRETING Thomas D. Johnston, Roberto Gedaly, Hoonbae Jeon, Dinesh Ranjan, Department of
Surgery, University of Kentucky, Lexington, USA
HEPATITIS C
P05 THE CHOICE OF CALCINEURIN INHIBITOR DOES NOT AFFECT POSTTRANSPLANTATION OUTCOMES IN TERMS OF HCV RECURRENCE: A RANDOMIZED PROSPECTIVE STUDY
Santos Jimenez-Galanes Marchán, Juan Carlos Meneu Diaz, Baltasar Perez Saborido, Yiliam Fundora Suarez, Almudena Moreno Elola-Olaso, Manuel Abradelo de Usera, Vanessa Barra Valencia, Felix Cambra Molero, Alberto Gimeno Calvo, Carlos Jimenez Romero, Rose Mari Lopez Sterup, Enrique Moreno Gonzalez, Surgery and Abdominal Organs Transplantation, 12 de Octubre University Hospital, Madrid, Spain
22
Posters
SMALL BOWEL TRANSPLANTATION
P06 THE IMPACT OF BASILIXIMAB ON RENAL FUNCTION AFTER PAEDIATRIC INTESTINAL TRANSPLANTATION
Mara Giovanelli, Girish L. Gupte, Paul Davies, Carla Lloyd, Deirdre A. Kelly, Darius F. Mirza, David A. Mayer, Khalid Sharif, Alastair J. Millar, Susan V. Beath, Liver Unit Birmingham Children’s Hospital, Surgery 3 Liver & Lung Transplant Centre - Ospedali Riuniti, Bergamo, Italy; Liver Unit Birmingham Children’s Hospital, Surgery 3 Liver & Lung Transplant Centre, Birmingham, United Kingdom
P07 RESULTS OF INTESTINAL AND MULTIVISCERAL TRANSPLANTATION IN ADULT PATIENTS: SPANISH EXPERIENCE
Santos Jimenez-Galanes Marchán, Juan Carlos Meneu Diaz, Baltasar Perez Saborido, Yiliam Fundora Suarez, Almudena Moreno Elola-Olaso,Vanessa Barra Valencia, Sergio Olivares Pizarro, Manuel Abradelo de Usera, Carlos Jimenez Romero, Enrique Moreno Gonzalez, Surgery and Abdominal Organs Transplantation, 12 de Octubre University Hospital, Madrid, Spain
P08 INCIDENCE OF HISTOPATHOLOGICAL DEMOSTRATED REJECTION IN OUR SERIES OF ADULTS UNDERWENT SMALL BOWEL TRANSPLANTATION
Santos Jimenez-Galanes, Juan Carlos Meneu Diaz, Baltasar Perez Saborido, Yiliam Fundora Suarez, Almudena Moreno Elola-Olaso, Sergio Olivares Pizarro, Vanessa Barra Valencia, Manuel Abradelo de Usera, Alberto Gimeno Calvo, Enrique Moreno Gonzalez, Surgery and Abdominal Organs Transplantation, 12 de Octubre University Hospital, Madrid, Spain
P09 CHRONIC REJECTION AFTER COMBINED LIVER AND SMALL BOWEL TRANSPLANTATION IN A CHILD WITH CHRONIC INTESTINAL PSEUDO-OBSTRUCTION
Mara Giovanelli, Girish L. Gupte, Khalid Sharif, Allistair J. Millar, David A. Mayer, Darius F. Mirza, Liver Unit Birmingham Children’s Hospital, Birmingham, United Kingdom
ELTR STUDIES
P10 DOMINO DONOR RISK TRANSPLANTATION. IS TECHNIQUE A FACTOR? Vitor M.Ribeiro, Luis M. Gra‡a, Jorge D. Silva, Jos D. Silva, Rui M. Almeida, Manuel C.
Teixeira, Surgery and Liver Transplantation, Hospital Santo António, Porto, Portugal
23
Posters
WORST CASES
P11 GRAFT VESSEL WALL PATHOLOGY IN A CASE OF HEPATIC ARTERY PSEUDO-ANEURYSM IN A LIVER TRANSPLANT RECIPIENT
Gian Luigi Adani, Umberto Baccarani, Vittorio Bresadola, Dario Lorenzin, Andrea Risaliti, Dino De Anna, Surgery & Transplantation, University, Udine, Italy
P12 3 CONSECUTIVE LIVER TRANSPLANTATIONS IN A PATIENT WITH REPEATED ACUTE GRAFT NECROSIS
Christina Schleicher, Heiner Wolters, Thomas Vogel, Norbert Senninger, Jens G. Brockmann, General and Transplant Surgery, University of Muenster, Muenster, Germany
BASIS SCIENCE
P13 DOSAGE DEPENDED ACETAMINOPHEN-INDUCED ACUTE LIVER FAILURE IN PIGS Martin Schenk, Christian Thiel, Karolin Knubben, Alexander Etspueler, Sofia
Rubitschek, Sabine Schmid, Felippe Vargas, Matthias H. Morgalla*, Alfred Königsrainer, Universitätsklinikum Tübingen, Klinik für Allgemeine, Viszeral-und Transplantationschirurgie, *Klinik für Neurochirurgie, Tübingen, Germany
MISCELLANEA
P14 COMBINED TREATMENT WITH SCLEROTHERAPY AND BANDING FOR VARICEAL BLEEDING IN CANDIDATES FOR LIVER TRANSPLANTATION: PRELIMINARY RESULTS
Lorenzo Norberto, Lino Polese, Umberto Cillo, Patrizia Burra, Alberto Brolese, Daniele Neri, Giacomo Zanus, Patrizia Boccagni, Alberto Pauletto, Davide F. D’Amico, Lorenzo Norberto, Department of Surgical and Gastroenterological Sciences, University of Padova, Policlinico Universitario, Padova, Italy
P15 INDIVIDUAL DRUG THERAPY IN LIVER TRANSPLANTATION Laszlo Kobori, Eniko Sarvary, Janos Fazakas, Attila Doros, Imre Fehervari, Denes Gorog,
Zsuzsanna Gerlei, Jeno Jaray, Katalin Monostory, Transplantation and Surgical Dep., Semmelweis University, Budapest, Hungary
P16 HEPATIC VENOUS HEMOGLOBIN OXYGEN SATURATION AS AN EARLY PREDICTOR OF LIVER FUNCTION IN ORTHOTOPIC LIVER TRANSPLANTATION
Chrysoula I. Papageorgiou, Vasilios G. Papanikolaou, Eleni F. Katsika, Aggeliki Parlapani, Dionisios V. Vrochides, Dimitrios N. Takoudas, 1st Anaesthesiology Department, University Hospital Hippokration, Thessaloniki, Greece
24
Posters
P17 OUTCOME OF HEPATICOJEJUNOSTOMY FOR BILIARY TRACT OBSTRUCTION FOLLOWING LIVER TRANSPLANTATION
Georg P. Györi, Felix B. Langer, Herwig Pokorny, Christoper K. Burghuber, Susanne Rockenschaub, Gabriela A. Berlakovich, Ferdinand Mühlbacher, Rudolf Steininger, Dep. of Clinical Transplantation, University Clinic of Surgery, Medical University, Vienna, Austria
P18 CLINICAL IMPACT OF OBESITY (BMI > 30) AFTER LIVER TRANSPLANTATION. Maria Clara Dezza, A. Rossetto, E. Sieders, Maurizio Sainz Barriga, Xavier Rogiers,
Roberto Troisi, Bernard De Hemptinne, Patrizia Burra*, Hepatobiliary and Liver Transplant Service, Ghent University Hospital, Ghent, Belgium; *Department of Surgery & Gastroenterological Sciences, Università degli Studi, Padova, Italy
P19 PHARMACOKINETICS, EFFICACY AND SAFETY OF INTRAMUSCOLAR AND INTRAVENOUS OF HEPATITIS B IMMUNOGLOBULINS COMBINED WITH NUCLEOSIDE ANALOGUES IN PROPHYLAXIS OF HEPATITIS B AFTER LIVER TRANSPLANTATION
Riccardo Volpes, Patrizia Burra, Pietro Andreone, Daniele Canova, Carmela Cursaro, Anna Riili, Bruno Fiorentino, Michela Bacci, Stefano Guazzino, Alfredo Marzano; ISMETT, Palermo, Azienda Ospedaliera, Padova; Azienda Ospedaliera S.Orsola Malpighi, Bologna; Kedrion S.p.A, UODU Gastroepatologia, A.O. San Giovanni Battista, Torino
P20 ANTIMICROBIAL PROPHYLAXISIN LIVER TRANSPLANTATION PATIENTS A MULTICENTER SURVEY
E. Vandecasteele, J. De Waele, S. Blot, D. Vandijck, D. Vogelaers, X. Rogiers, M. Bourgeois, J. Decruyenaere, E. Hoste; University Hospital Ghent, Department of Clinical Care, Az Sint-Jan Bruges, Department of Clinical Care, University Hospital Ghent, Department of International of International Medicine, University Hospital Ghent, Department of Surgery
25
Awards26
THE FOLLOWING
ELITA 2008 YOUNG INVESTIGATOR AWARDS
are assigned for the outstanding quality of the Abstract Submitted
O01 MELATONIN PROTECTS FROM HEPATIC REPERFUSION INJURY THROUGH INHIBITION OF IKK AND JNK PATHWAYS AND MODIFICATION OF CELL PROLIFERATION
Arash Nickkholgh, Rui Liang, Katrin Hoffmann, Michael Kern, Heinz Schneider, Michael Sobirey, Markus Zorn, Markus W. Böchler, Peter Schemmer, Dept. of General Surgery, Ruprecht-Karls University, Heidelberg, Germany; Dept. of Pathology, Ruprecht-Karls University, Heidelberg, Germany; HealthEcon AG, Basel, Switzerland; Nutri~Fit GmbH & Co KG, Mühlen, Germany; Central Laboratory, Ruprecht-Karls University, Heidelberg, Germany
O04 PROSPECTIVE STUDY OF NATURAL KILLER (NK) CELL PHENOTYPE IN RECURRING
HCV INFECTION FOLLOWING LIVER TRANSPLANTATION B. Oliviero, S. Varchetta, F. Donato, F. Agnelli, G. Rossi, M. Berra, C. Rigamonti, Massimo
Colombo, D. Mavilio, Mario U. Mondelli, Infectious Diseases, IRCCS Fondazione San Matteo and University of Pavia, Pavia, Italy; Gastroenterology and Liver Transplantation Unit, IRCCS Fondazione Policlinico-Mangiagalli-Regina Elena, Milan, Italy; Laboratory of Immunoregulation, NIAID, NIH, Bethesda, USA
O32 RETRANSPLANTATION RATE IS SIGNIFICANTLY HIGHER IN DONATION AFTER
CARDIAC DEATH AND INDIPENDENT FROM THE RECIPIENT STATUS Maria Clara Dezza, F. Berrevoet, Maurizio Sainz Barriga, A. Rossetto, Xavier Rogiers,
Bernard De Hemptinne, Roberto Troisi, Hepatobiliary Service, Ghent University Hospital, Ghent, Belgium
27
28
ACCREDITATIONThe 4th ELITA – ELTR Winter Meeting is accredited by the Italian Ministery of Health with 7 CME credits (for Italian Doctors only).
ORAL SESSIONSAbstracts selected are presented during the Oral Sessions 1 to 6, as oral presentation of 10’ or 12’.
POSTER SESSIONSAll posters presentations have been assigned a chronological programme number, for reference when locating your printed abstract, in the Supplement of Transplant International. The same number indicates also the board number location.Abstracts selected as posters will be on displayed throughout the Congress in Room F.
Mount Time: Thursday 3 April, 2008 13h00 - 17h00
POSTER VIEWING & WELCOME COCKTAIL Thursday 3 April, 2008 18h30 - 19h30
Display Time: Friday 4 April, 2008 08h30 - 18h00 Saturday 5 April, 2008 08h30 - 13h00
Dismount Time: Saturday 5 April, 2008 13h00 - 13h30
There will not be organized or moderated discussions over Posters.
PUBLICATION OF ABSTRACTSAll accepted abstracts are published in the Volume 21, Supplement 1, 2008 of Transplant International.
REGISTRATIONParticipants are requested to wear their badge to move around the Congress Centre. All Presenters of Oral and Poster presentations must be registered to the Meeting.
CERTIFICATE OF PARTICIPATIONA Certificate of Participation will be available on request at Registration/Organizing Secretariat Desk.
ELITA-ELTR Scientific Information
29
ELITA-ELTR Scientific Information
INFORMATION FOR SPEAKERS & CHAIRMENAudiovisual equipment is provided for PowerPoint presentation in all sessions of the Meeting. Speakers and presenters are requested to report to technician in the Meeting Room, at least 1 hour prior their session time, to download their presentation in the main computer. Usage of personal PC is not permitted. Staff will assist you during the running of the session. A technician will also be available to assist in using the audio-visual facilities in the meeting room.Speakers and Chairmen are asked to report in the Meeting room 10 minutes before the starting time of the session. Please keep strictly to the time assigned for your presentation, as set out in the Final Programme.All presentations must be in English, as this is the language of the Congress. Simultaneous translation is not provided.
Audience and presenters are requested to turn off all mobile phones and pagers during the presentations. SOCIAL EVENTS
POSTER VIEWING AND WELCOME COCKTAILThursday, 3 April 2008 at 18h40 – Alexander Girardi Congress Hall
The Poster Area will open with a welcome cocktail, with the aim to gather all congress Participants.
An exhibit of paintings and sculptures will be presented by the artists:Franziska Koenigsrainer, Bea Lerut, Sir Roy Calne, Lucio Caccamo, Massimo Nube and Franco Cimitan by Santo Stefano Art Gallery in Venice.
4th ELITA-ELTR WINTER MEETING DINNER AND ELITA REUNION
A special dinner will be organized at the restaurant “El Camineto”, a typical restaurant with a fantastic view on the Ampezzo Valley. The venue is reachable by car within ten minutes from all the hotels, however a shuttle bus service is provided. All participants are invited to attend, reservation will be possible until Thursday, April 3 and upon availability.Cost for the dinner is 60 Euro.Bus Departure: 20h15 in front of the main entrance of the Church SS. Filippo e Giacomo, Piazza Roma - Return Transfers will run from approximately 23h00
Al Caminetto, 1, Località Rumerlo, Cortina d’Ampezzo
During the dinner Prof. Paul Mc Master, will make a presentation on “The past history and new prospective for ELITA”
CONGRESS VENUEAlexander Hall - Centro CongressiVia Marangoni, 1 - Cortina d’AmpezzoTel. +39 0436 881850 - Fax +39 0436 [email protected] - www.cortinameeting.org
ORGANIZING SECRETARIAT AND REGISTRATION DESK The Organizing Secretariat will be located at the Congress Venue.The opening time will be the following:
Thursday, April 3 15h00 – 19h00
Friday, April 4 08h00 – 12h30 15h30 – 18h00
Saturday, April 5 08h00 – 13h30
ELITA SHUTTLE BUSA special service for ELITA Speakers & Participants will run
from Venice Marco Polo Airport to Cortina - Congress Centre and Hotel Ancora - at the following time:
Thursday April 3, 2008 11h00 – 13h00 15h00 – 18h00
Friday April 4, 2008 09h30
from Cortina - Congress Centre and Hotel Ancora - to Venice Marco Polo Airport, at the following time:
Saturday April 5, 2008 11h00 – 13h00 – 15h00
USEFUL NUMBERS AND ADDRESSESTourist Office: Cortina Turismo - via Marconi, 15/Bphone +39 0436 866252 - www.cortina.dolomiti.org
POST OFFICELargo Postephone +39 0436 862411fax +39 0436 882440
30
General Information
CAR RENTALSCortina Auto – Zuel di Sopra, 53phone +39 0436 867547Garage Dolomiti - Corso Italia 186/188phone +39 0436.861345Servizi Ampezzo – Autostazione via Marconiphone +39 0436.867921
BUS STATIONDolomitibus – Via Col da Ren, 14 – Bellunophone +39 0437 941137 / 21711
Taxi phone +39 0436 860888 - +39 0436 2839+39 0436 4619
Hospitalphone +39 0436 883111
Mountain rescuephone +39 0436 2943 or 118
Emergency numberphone 112
Municipalityphone +39 0436 4291
BANKINGBanks in Italy are open from 08h30 to 13h00 and from 14h30 to 15h30, Monday to Friday. Exchange facilities are available at arriving airport, in town and at major hotels.
INSURANCEOrganizers do not accept liability for any injury, loss or damage, arising from accidents or other situations during, or as a consequence of the Congress. Participants are therefore advised to arrange for health and accident insurance prior to travelling.
31
General Information
Ack
now
ledg
emen
ts
4TH ELITA-ELTR WINTER MEETING SUPPORTERSThe ELITA Board and the Meeting Chair express their thanks to the following Companies, for their support:
EXCLUSIVE
MAJOR
SUPPORTERS & EXHIBITORS
BERNA BIOTECHBIOTESTGENZYMEROCHE
WYETH EUROPESOFAR
PADOVA UNIVERSITY
32
Exhibit
We invite you to visit our Exhibitors,at the following time:
Thursday, April 3, 16h00 – 19h00Friday, April 4, 08h30 – 12h30 16h00 – 18h00Saturday, April 5, 08h30 – 12h30
33
FRESENIUSBERN
ABIOTECH
ASTE
LLAS
Regi
stra
tion
Desk
Coffee break
Coffee break
Entrance
GENZYME KEDRION
MINNAJAFoundation
ASS. “Facciamo
un nido”
34
Notes
Astellas has always prided itself on
its heritage and focus. And that’s
not going to change.
In transplantation, Astellas markets
an immunosuppressant to prevent
organ rejection in heart, kidney and
liver transplants. In the development
pipeline are further novel products
for the prevention of organ rejection
post-transplant and for the optimisation
of patient management.
With an annual projected R&D spend
of 1.6 billion dollars, at Astellas we can
continue to concentrate our efforts
on those specialised therapeutic areas
that have already benefited from
our expertise.
Astellas, a consistent force for today, an inspiration for the future and a leading light for life.
Shining in transplantationHeart
Liver
Kidney
Astellas: Now a leading light in heart transplantation
www.astellas.com/eu
C61128
LASERS PRINTED AT 100 %
MECH
AN
ICAL
Job #: MREU
-0102 Corporate Ad Resize ELITA
Winter M
eeting Abstract Book
Bleed Size: 282mm
H × 216m
m W
Trim
Size: 276mm
H × 210m
m W
Live Size: 245m
m H
× 180mm
WPrints: 4/0: 4C —
•C •M •Y •K
First round mechanical built by: CF
Magenta rules indicate BLEED
– TRIM – LIVE —
DO
NO
T PRINT
MREU-0102_CorpAd_ELITA_m3.indd 1 1/4/08 2:47:11 PM
KEEP LIFE FLOWING
Everyone has the right to life, liberty and security of person*
Sometimes, natural, accidental or social causes obstruct the natural right to life, liberty and personal security.
Because of the special nature of its products, Kedrion supports people, communities and institutions in reducing or removing those obstacles that prevent people enjoying such rights. Kedrion helps turn the natural rights (life, liberty, security) into the social right to live in the best possible conditions.
For this reason, it collects and converts, makes active and usable that vital energy that is generated and regenerated, preserved and carried through blood; so that it can be transferred from one human being to the next, and anyone can enjoy one’s fundamental rights.
*Universal Declaration of Human Rights, art. 3.